Dr. Satoshi Takamatsu is the President and CEO of ARCALIS, a pioneering mRNA CDMO dedicated to advancing end-to-end mRNA manufacturing solutions. With extensive experience in the biopharmaceutical industry, Satoshi has played a key role in establishing ARCALIS as a leading partner for mRNA therapeutics. Under his leadership, ARCALIS has expanded its capabilities to support global mRNA production, ensuring high-quality and scalable solutions for pharmaceutical and biotech partners. His expertise in strategic development and biomanufacturing innovation continues to drive ARCALIS’ mission to transform the future of mRNA medicines.